Infliximab Plus Methotrexate for the Treatment of Rheumatoid Arthritis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00269867
Recruitment Status : Completed
First Posted : December 26, 2005
Last Update Posted : November 4, 2014
Information provided by (Responsible Party):
Centocor, Inc.